SCHEMBL15912403

SCHEMBL15912403

CN1CCC(c2ccc(C3(C(=O)O)CC3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 6/20 0.52
CYP3A4 P08684 2/20 0.49
APP P05067 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
QDPR P09417 2/20 0.46
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
SIGMAR1 Q99720 6/20 0.43
KDM1A O60341 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735267 0.93 AKR1C1 (0.49) HSD11B1CYP3A4SIGMAR1AKR1C1
SCHEMBL31045643 0.85 CYP3A4 (0.56) HSD11B1CYP3A4APPCYP2D6CYP2C9
SCHEMBL348524 0.82 CYP3A4 (0.64) HSD11B1CYP3A4APPCYP2D6CYP2C9
SCHEMBL31045651 0.82 CYP3A4 (0.60) HSD11B1CYP3A4APPCYP2D6CYP2C9
SCHEMBL9786867 0.76 CYP3A4 (0.61) HSD11B1CYP3A4APPCYP2D6CYP2C9
SCHEMBL1305458 0.76 HDAC3 (0.55) QDPRHDAC3HDAC4HDAC1HDAC7
SCHEMBL3099869 0.75 HSD11B1 (0.49) HSD11B1CYP3A4APPCYP2D6CYP2C9
SCHEMBL17888245 0.74 OPRM1 (0.64) CYP2C19AKR1C1
Hydrochloric Acid SCHEMBL4652141 0.74 KDM1A (0.54) QDPRHDAC3HDAC4HDAC1HDAC7
Acetic Acid SCHEMBL29567593 0.74 QDPR (0.56) QDPRHDAC3HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140213538-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140213538-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS LPAR1, LPAR2, LPAR5 HSD11B1 2652/4885CYP3A4 4748/4885APP 2529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.